2020
DOI: 10.1016/j.eururo.2020.05.018
|View full text |Cite
|
Sign up to set email alerts
|

Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
89
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

4
6

Authors

Journals

citations
Cited by 77 publications
(91 citation statements)
references
References 22 publications
1
89
0
1
Order By: Relevance
“…Novel study designs, such as cohort-embedded RCTs, should be encouraged and supported [52]. It would be imperative to use standardised criteria and validated thresholds in terms of patient eligibility, definitions of interventions, imaging modalities during treatment and monitoring, repeat treatments within a predefined timescale, biopsy schedules during follow-up, and outcome measures assessed at appropriate intervals and follow-up duration, since there is significant heterogeneity regarding FT [53,54]. The use of patient-reported outcome measures to measure functional and QoL outcomes should be encouraged.…”
Section: Implications For Clinical Practice and Further Researchmentioning
confidence: 99%
“…Novel study designs, such as cohort-embedded RCTs, should be encouraged and supported [52]. It would be imperative to use standardised criteria and validated thresholds in terms of patient eligibility, definitions of interventions, imaging modalities during treatment and monitoring, repeat treatments within a predefined timescale, biopsy schedules during follow-up, and outcome measures assessed at appropriate intervals and follow-up duration, since there is significant heterogeneity regarding FT [53,54]. The use of patient-reported outcome measures to measure functional and QoL outcomes should be encouraged.…”
Section: Implications For Clinical Practice and Further Researchmentioning
confidence: 99%
“…Although mpMRI has provided an excellent platform for localization and image-guidance, it cannot accurately display the boundaries of all cancers and many cancers remain MRI-invisible [10]. Finally, after the focal treatment, it remains challenging to evaluate treatment efficacy by the interpretation of the serum PSA, imaging-and biopsy results during follow-up as well as, the actual quality of life occurring after the intervention [11,12].…”
mentioning
confidence: 99%
“…However, proxy outcomes for long-term (ie, 10-yr) outcomes will need to be used thoughtfully and pragmatically given the challenges of recruiting patients to trials in the FT setting. Importantly, efforts are ongoing to standardize the definitions of FT treatment and patient selection criteria [5][6][7]. In a parallel to the radiation oncology space, which has many different forms of radiation treatment, many practitioners of FT believe in the equipoise of the various energy sources.…”
mentioning
confidence: 99%